Target intelligence / Profile preview

Exogenous and Endogenous Toxins

Molecular classification
Other
01

Overview

Exogenous and endogenous toxins represent a broad category of deleterious substances that disrupt physiological homeostasis and drive the progression of numerous diseases. Exogenous toxins, or xenobiotics, include environmental pollutants, heavy metals, drugs, and bacterial exotoxins that enter the body from external sources. Endogenous toxins are harmful products generated internally, such as reactive oxygen species (ROS), metabolic waste products like urea and ammonia, and excessively produced cytokines during systemic inflammatory responses. These substances contribute to pathologies including chemical atherogenesis, acute kidney injury, neurodegeneration, and sepsis by inducing oxidative stress and activating chronic inflammatory cascades. Therapeutic approaches to manage these toxins focus on neutralization through pharmacological antidotes, enhancement of metabolic detoxification pathways, or physical removal via extracorporeal blood purification technologies. Because this term encompasses a vast and chemically diverse group of molecules rather than a single specific receptor or enzyme, it is classified as a broad clinical and toxicological category.

Other names
Exotoxins and endotoxinsXenobioticsEnvironmental pollutantsMetabolic toxinsPro-inflammatory mediatorsUremic toxins
02

Mechanism of action

Drugs and medical devices targeting these substances operate through physical adsorption, chemical chelation, enzymatic neutralization, or the augmentation of endogenous antioxidant systems to mitigate systemic toxicity and prevent organ damage.

03

Biological functions

Induction of oxidative stressPromotion of systemic inflammationDisruption of lipid metabolismCovalent modification of proteins and DNAActivation of cell death pathways
04

Disease associations

AtherosclerosisSepsisAcute kidney injuryNeurodegenerative diseaseChronic kidney diseaseCancer
05

Safety considerations

Non-selective removal of essential nutrients and therapeutic drugs during adsorptionRisk of electrolyte and fluid imbalances during intensive detoxificationPotential for secondary inflammatory responses during toxin release or neutralizationChallenges in quantifying total toxic load for precise dosing
06

Interacting drugs

Activated charcoal

5 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS)Interleukin-6 (IL-6)Tumor necrosis factor alpha (TNF-alpha)Malondialdehyde (MDA)CreatinineReactive oxygen species (ROS)

Beyond the preview

Go deeper on Exogenous and Endogenous Toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exogenous and Endogenous Toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call